Abstract
Background
This study was performed to evaluate the safety and efficacy of photodynamic therapy with the carboxyfluorescein ester BCECF-AM as an adjunctive treatment procedure for pterygium surgery to reduce the rate of recurrence.
Methods
In this nonrandomized prospective clinical trial, 19 eyes with nasally located primary pterygium were examined. All eyes were treated with the bare sclera surgical technique. Seven eyes received in addition treatment with BCECF-AM solution and blue light. All patients were evaluated at least after 1 day, 1 week, 1 month, 3 months, and 1 year. Postoperative fibrovascular growth from the limbus of at least 1 mm was defined as recurrence.
Results
The intraoperative application of BCECF-AM solution did not cause anterior chamber flare or any other significant side effects. The bare sclera surgery rate of recurrence was 0% (zero of 12) after 3 months and 91% (11 of 12) after 1 year. The additional photodynamic therapy treatment had a rate of recurrence of 14.2% (one of seven) after 3 months and 71.4% (five of seven) after 1 year.
Conclusions
The applied PDT technique seems to be a safe procedure but is associated with a high rate of recurrence. In conclusion, the evaluated PDT treatment procedure, at this point, should not be considered. As we found a high rate of recurrence also in the control group, the bare sclera technique is not effective, even in primary pterygia.
Similar content being viewed by others
References
Alaniz-Camino F (1982) The use of postoperative beta radiation in the treatment of pterygia. Ophthalmic Surg 13:1022–1025
Amano S, Motoyama Y, Oshika T, Eguchi S, Eguchi K (2000) Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol 84:618–621
Anduze AL (2001) Pterygium surgery with mitomycin-C: ten-year results. Ophthalmic Surg Lasers 32:341–345
Bayer A, Mutlu FM, Sobaci G (2002) Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis. Ophthalmic Surg Lasers 33:58–61
Chaidaroon W, Wattananikorn S (2003) Conjunctival autograft transplantation for primary pterygium. J Med Assoc Thai 86:111–115
Dadeya S, Kamlesh (2001) Intraoperative daunorubicin to prevent the recurrence of pterygium after excision. Cornea 20:172–174
Davidorf J, Davidorf F (1992) Treatment of iris melanoma with photodynamic therapy. Ophthalmic Surg 23:522–527
Diestelhorst M, Grisanti S (2002) Photodynamic therapy to control fibrosis in human glaucomatous eyes after trabeculectomy: a clinical pilot study. Arch Ophthalmol 120:130–134
Dougherty PJ, Hardten DR, Lindstrom RL (1996) Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 15:537–540
Dougherty TJ (2002) An update on photodynamic therapy applications. J Clin Laser Med Surg 20:3–7
Frucht-Pery J, Siganos CS, Ilsar M (1996) Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 103:674–677
Fujitani A, Hayasaka S, Shibuya Y, Noda S (1993) Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica 207:162–164
Gohto Y, Obana A, Kanai M, Nagata S, Miki T, Nakajima S (2000) Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na). Ophthalmic Surg Lasers 31:55–60
Grimes PA, Stone RA, Laties AM, Li W (1982) Carboxyfluorescein. A probe of the blood-ocular barriers with lower membrane permeability than fluorescein. Arch Ophthalmol 100:635–639
Grisanti S, Diestelhorst M, Heimann K, Krieglstein G (1999) Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery. Br J Ophthalmol 83:1353–1359
Grisanti S, Gralla A, Maurer P, Diestelhorst M, Krieglstein G, Heimann K (2000) Cellular photoablation to control postoperative fibrosis in filtration surgery: in vitro studies. Exp Eye Res 70:145–152
Hill RA, Crean DH, Doiron DR, McDonald TJ, Liaw LH, Ghosheh F, Hamilton A, Berns MW (1997) Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery. Ophthalmic Surg Lasers 28: 574–581
Hofmann J, Sernetz M (1983) A kinetic study on the enzymatic hydrolysis of fluorescein diacetate and fluorescein-di-beta-d-galactopyranoside. Anal Biochem 131:180–186
Kraut A, Drnovsek-Olup B (1996) Instillation of mitomycin C after recurrent pterygium surgery. Eur J Ophthalmol 6:264–267
Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105:901–905
Maldonado MJ, Cano-Parra J, Navea-Tejerina A, Cisneros AL, Vila E, Menezo JL (1995) Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium. Arch Ophthalmol 113:1356–1357
Manning CA, Kloess PM, Diaz MD, Yee RW (1997) Intraoperative mitomycin in primary pterygium excision. A prospective, randomized trial. Ophthalmology 104:844–848
Oguz H, Basar E, Gurler B (1999) Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Acta Ophthalmol Scand 77:147–150
Pikkel J, Porges Y, Ophir A (2001) Halting pterygium recurrence by postoperative 5-fluorouracil. Cornea 20:168–171
Raab O (1900) Ueber die Wirkung floureszierender Stoffe auf Infusorien. Z Biol 39:524–546
Rotman B, Papermaster BW (1966) Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci U S A 55:134–141
Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG (1992) Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 99:1647–1654
Rubinfeld RS, Stein RM (1997) Topical mitomycin-C for pterygia: is single application appropriate? Ophthalmic Surg Lasers 28:662–669
Safianik B, Ben-Zion I, Garzozi HJ (2002) Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol 86:357–358
Saifuddin S, el Zawawi A (1995) Scleral changes due to mitomycin C after pterygium excision: a report of two cases. Indian J Ophthalmol 43:75–76
Simona F, Anastasi-Forni C, Benedetti C, Failla FG, Rossi FM, Meyer U (1994) Adjuvant treatment with mitomycin eyedrops after pterygium excision: Ticino experience. Klin Monatsbl Augenheilkd 204:409–412
Singh G, Wilson MR, Foster CS (1988) Mitomycin eye drops as treatment for pterygium. Ophthalmology 95:813–821
Sridhar MS, Bansal AK, Rao GN (2002) Surgically induced necrotizing scleritis after pterygium excision and conjunctival autograft. Cornea 21:305–307
Tsai YY, Lin JM, Shy JD (2002) Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea 21:227–229
Urbach F, Forbes PD, Davies RE, Berger D (1976) Cutaneous photobiology: past, present and future. J Invest Dermatol 67:209–224
Van Tenten Y, Schuitmaker HJ, De Groot V, Willekens B, Vrensen GF, Tassignon MJ (2002) A preliminary study on the prevention of posterior capsule opacification by photodynamic therapy with bacteriochlorin a in rabbits. Ophthalmic Res 34:113–118
Wilson CA, Saloupis P, Hatchell DL (1991) Treatment of experimental preretinal neovascularization using photodynamic thrombosis. Invest Ophthalmol Vis Sci 32:2530–2535
Wong VA, Law FC (1999) Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians. Ophthalmology 106:1512–1515
Acknowledgements
The authors have no proprietary or financial interest. No grants or funds were received in support of the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hueber, A., Grisanti, S. & Diestelhorst, M. Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study. Graefe's Arch Clin Exp Ophthalmol 243, 942–946 (2005). https://doi.org/10.1007/s00417-004-1114-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-004-1114-5